4-Methyl-2-(pyrazin-2-yl)thiazole-5-carboxylic acid, 95+%, 250mg

Methyl 1,3-Benzoxazole-7-carboxylate, 97.0%, 10g

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 10mg

Ethyl 4-ethyl-3-methyl-1H-pyrrole-2-carboxylate, 97%, 500mg

N-METHYLPYRIDINE-2-CARBOXAMIDE, 95%, 5g

4-(2-Fluoro-4-nitrophenoxy)quinolin-7-ol, 95.0%, 250mg

1,3-Dihydro-2H-imidazo[4,5-b]pyrazin-2-one, 95.0%, 250mg

1-Decanol, min 99%, for synthesis, 1L, glass packaging

(S)-2,4-bis((tert-butoxycarbonyl)amino)butanoic acid, 96%, 5g

(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride, 95.0%, 25g

2-[2-(4-ethoxyphenyl)-1H-1,3-benzodiazol-6-yl]-6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazole trihydrochloride, 98%, 10mg

5-Hydroxy-nicotinic acid, 97.0%, 500g

4-Iodo-m-xylene>98.0%(GC)25g